1 Study Coverage 1.1 Hyperimmune Serum Product Introduction 1.2 Market by Type 1.2.1 Global Hyperimmune Serum Market Size Growth Rate by Type 1.2.2 Hepatitis B Immunoglobulins 1.2.3 Rabies Immunoglobulins 1.2.4 Tetanus Immunoglobulins 1.2.5 Rho(D) Immunoglobulins 1.2.6 Other 1.3 Market by Application 1.3.1 Global Hyperimmune Serum Market Size Growth Rate by Application 1.3.2 Government Institutions 1.3.3 Private Sector 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Hyperimmune Serum Market Size, Estimates and Forecasts 2.1.1 Global Hyperimmune Serum Revenue 2016-2027 2.1.2 Global Hyperimmune Serum Sales 2016-2027 2.2 Global Hyperimmune Serum, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Hyperimmune Serum Historical Market Size by Region (2016-2021) 2.3.1 Global Hyperimmune Serum Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Hyperimmune Serum Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Hyperimmune Serum Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Hyperimmune Serum Sales Forecast by Region (2022-2027) 2.4.2 Global Hyperimmune Serum Revenue Forecast by Region (2022-2027) 3 Global Hyperimmune Serum Competitor Landscape by Players 3.1 Global Top Hyperimmune Serum Manufacturers by Sales 3.1.1 Global Hyperimmune Serum Sales by Manufacturer (2016-2021) 3.1.2 Global Hyperimmune Serum Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Hyperimmune Serum Manufacturers by Revenue 3.2.1 Key Hyperimmune Serum Manufacturers Covered: Ranking by Revenue 3.2.2 Global Hyperimmune Serum Revenue by Manufacturers (2016-2021) 3.2.3 Global Hyperimmune Serum Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Hyperimmune Serum Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Hyperimmune Serum Revenue in 2020 3.2.6 Global Hyperimmune Serum Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Hyperimmune Serum Price by Manufacturers 3.4 Global Hyperimmune Serum Manufacturing Base Distribution, Product Types 3.4.1 Hyperimmune Serum Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Hyperimmune Serum Product Type 3.4.3 Date of International Manufacturers Enter into Hyperimmune Serum Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Hyperimmune Serum Market Size by Type (2016-2021) 4.1.1 Global Hyperimmune Serum Sales by Type (2016-2021) 4.1.2 Global Hyperimmune Serum Revenue by Type (2016-2021) 4.1.3 Hyperimmune Serum Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Hyperimmune Serum Market Size Forecast by Type (2022-2027) 4.2.1 Global Hyperimmune Serum Sales Forecast by Type (2022-2027) 4.2.2 Global Hyperimmune Serum Revenue Forecast by Type (2022-2027) 4.2.3 Hyperimmune Serum Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Hyperimmune Serum Market Size by Application (2016-2021) 5.1.1 Global Hyperimmune Serum Sales by Application (2016-2021) 5.1.2 Global Hyperimmune Serum Revenue by Application (2016-2021) 5.1.3 Hyperimmune Serum Price by Application (2016-2021) 5.2 Hyperimmune Serum Market Size Forecast by Application (2022-2027) 5.2.1 Global Hyperimmune Serum Sales Forecast by Application (2022-2027) 5.2.2 Global Hyperimmune Serum Revenue Forecast by Application (2022-2027) 5.2.3 Global Hyperimmune Serum Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Hyperimmune Serum Market Size YoY Growth 2016-2027 6.1.1 Japan Hyperimmune Serum Sales YoY Growth 2016-2027 6.1.2 Japan Hyperimmune Serum Revenue YoY Growth 2016-2027 6.1.3 Japan Hyperimmune Serum Market Share in Global Market 2016-2027 6.2 Japan Hyperimmune Serum Market Size by Players (International and Local Players) 6.2.1 Japan Top Hyperimmune Serum Players by Sales (2016-2021) 6.2.2 Japan Top Hyperimmune Serum Players by Revenue (2016-2021) 6.3 Japan Hyperimmune Serum Historic Market Review by Type (2016-2021) 6.3.1 Japan Hyperimmune Serum Sales Market Share by Type (2016-2021) 6.3.2 Japan Hyperimmune Serum Revenue Market Share by Type (2016-2021) 6.3.3 Japan Hyperimmune Serum Price by Type (2016-2021) 6.4 Japan Hyperimmune Serum Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Hyperimmune Serum Sales Forecast by Type (2022-2027) 6.4.2 Japan Hyperimmune Serum Revenue Forecast by Type (2022-2027) 6.4.3 Japan Hyperimmune Serum Price Forecast by Type (2022-2027) 6.5 Japan Hyperimmune Serum Historic Market Review by Application (2016-2021) 6.5.1 Japan Hyperimmune Serum Sales Market Share by Application (2016-2021) 6.5.2 Japan Hyperimmune Serum Revenue Market Share by Application (2016-2021) 6.5.3 Japan Hyperimmune Serum Price by Application (2016-2021) 6.6 Japan Hyperimmune Serum Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Hyperimmune Serum Sales Forecast by Application (2022-2027) 6.6.2 Japan Hyperimmune Serum Revenue Forecast by Application (2022-2027) 6.6.3 Japan Hyperimmune Serum Price Forecast by Application (2022-2027) 7 North America 7.1 North America Hyperimmune Serum Market Size YoY Growth 2016-2027 7.2 North America Hyperimmune Serum Market Facts & Figures by Country 7.2.1 North America Hyperimmune Serum Sales by Country (2016-2021) 7.2.2 North America Hyperimmune Serum Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Hyperimmune Serum Market Size YoY Growth 2016-2027 8.2 Asia Pacific Hyperimmune Serum Market Facts & Figures by Region 8.2.1 Asia Pacific Hyperimmune Serum Sales by Region (2016-2021) 8.2.2 Asia Pacific Hyperimmune Serum Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Hyperimmune Serum Market Size YoY Growth 2016-2027 9.2 Europe Hyperimmune Serum Market Facts & Figures by Country 9.2.1 Europe Hyperimmune Serum Sales by Country (2016-2021) 9.2.2 Europe Hyperimmune Serum Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Hyperimmune Serum Market Size YoY Growth 2016-2027 10.2 Latin America Hyperimmune Serum Market Facts & Figures by Country 10.2.1 Latin America Hyperimmune Serum Sales by Country (2016-2021) 10.2.2 Latin America Hyperimmune Serum Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Hyperimmune Serum Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Hyperimmune Serum Market Facts & Figures by Country 11.2.1 Middle East and Africa Hyperimmune Serum Sales by Country (2016-2021) 11.2.2 Middle East and Africa Hyperimmune Serum Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 CSL Behring 12.1.1 CSL Behring Corporation Information 12.1.2 CSL Behring Description and Business Overview 12.1.3 CSL Behring Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 12.1.4 CSL Behring Hyperimmune Serum Products Offered 12.1.5 CSL Behring Recent Development 12.2 Grifols 12.2.1 Grifols Corporation Information 12.2.2 Grifols Description and Business Overview 12.2.3 Grifols Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Grifols Hyperimmune Serum Products Offered 12.2.5 Grifols Recent Development 12.3 Biotest 12.3.1 Biotest Corporation Information 12.3.2 Biotest Description and Business Overview 12.3.3 Biotest Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Biotest Hyperimmune Serum Products Offered 12.3.5 Biotest Recent Development 12.4 Kedrion 12.4.1 Kedrion Corporation Information 12.4.2 Kedrion Description and Business Overview 12.4.3 Kedrion Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Kedrion Hyperimmune Serum Products Offered 12.4.5 Kedrion Recent Development 12.5 CBPO 12.5.1 CBPO Corporation Information 12.5.2 CBPO Description and Business Overview 12.5.3 CBPO Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 12.5.4 CBPO Hyperimmune Serum Products Offered 12.5.5 CBPO Recent Development 12.6 Emergent (Cangene) 12.6.1 Emergent (Cangene) Corporation Information 12.6.2 Emergent (Cangene) Description and Business Overview 12.6.3 Emergent (Cangene) Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Emergent (Cangene) Hyperimmune Serum Products Offered 12.6.5 Emergent (Cangene) Recent Development 12.7 Kamada 12.7.1 Kamada Corporation Information 12.7.2 Kamada Description and Business Overview 12.7.3 Kamada Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Kamada Hyperimmune Serum Products Offered 12.7.5 Kamada Recent Development 12.8 CNBG 12.8.1 CNBG Corporation Information 12.8.2 CNBG Description and Business Overview 12.8.3 CNBG Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 12.8.4 CNBG Hyperimmune Serum Products Offered 12.8.5 CNBG Recent Development 12.9 Hualan Bio 12.9.1 Hualan Bio Corporation Information 12.9.2 Hualan Bio Description and Business Overview 12.9.3 Hualan Bio Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Hualan Bio Hyperimmune Serum Products Offered 12.9.5 Hualan Bio Recent Development 12.10 Shanghai RAAS 12.10.1 Shanghai RAAS Corporation Information 12.10.2 Shanghai RAAS Description and Business Overview 12.10.3 Shanghai RAAS Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Shanghai RAAS Hyperimmune Serum Products Offered 12.10.5 Shanghai RAAS Recent Development 12.11 CSL Behring 12.11.1 CSL Behring Corporation Information 12.11.2 CSL Behring Description and Business Overview 12.11.3 CSL Behring Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 12.11.4 CSL Behring Hyperimmune Serum Products Offered 12.11.5 CSL Behring Recent Development 12.12 ADMA Biologics 12.12.1 ADMA Biologics Corporation Information 12.12.2 ADMA Biologics Description and Business Overview 12.12.3 ADMA Biologics Hyperimmune Serum Sales, Revenue and Gross Margin (2016-2021) 12.12.4 ADMA Biologics Products Offered 12.12.5 ADMA Biologics Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Hyperimmune Serum Industry Trends 13.2 Hyperimmune Serum Market Drivers 13.3 Hyperimmune Serum Market Challenges 13.4 Hyperimmune Serum Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Hyperimmune Serum Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Hyperimmune Serum Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Hepatitis B Immunoglobulins Table 3. Major Manufacturers of Rabies Immunoglobulins Table 4. Major Manufacturers of Tetanus Immunoglobulins Table 5. Major Manufacturers of Rho(D) Immunoglobulins Table 6. Major Manufacturers of Other Table 7. Global Hyperimmune Serum Market Size Growth Rate by Application (2021-2027) & (Kiloton) Table 8. Global Hyperimmune Serum Market Size by Region (Kiloton) & (US$ Million), 2016 VS 2021 VS 2027 Table 9. Global Hyperimmune Serum Sales by Regions (2016-2021) & (Kiloton) Table 10. Global Hyperimmune Serum Sales Market Share by Regions (2016-2021) Table 11. Global Hyperimmune Serum Revenue by Regions (2016-2021) & (US$ Million) Table 12. Global Hyperimmune Serum Sales Forecast by Region (2022-2027) & (Kiloton) Table 13. Global Hyperimmune Serum Sales Market Share Forecast by Region (2022-2027) Table 14. Global Hyperimmune Serum Revenue Forecast by Region (2022-2027) & (US$ Million) Table 15. Global Hyperimmune Serum Revenue Market Share Forecast by Region (2022-2027) Table 16. Global Hyperimmune Serum Sales by Manufacturers (2016-2021) (Kiloton) Table 17. Global Hyperimmune Serum Sales Share by Manufacturers (2016-2021) Table 18. Ranking of Global Top Hyperimmune Serum Manufacturers by Revenue (US$ Million) in 2020 Table 19. Hyperimmune Serum Revenue by Manufacturers (2016-2021) (US$ Million) Table 20. Hyperimmune Serum Revenue Share by Manufacturers (2016-2021) Table 21. Global Hyperimmune Serum Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 22. Global Hyperimmune Serum by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperimmune Serum as of 2020) Table 23. Key Manufacturers Hyperimmune Serum Price (2016-2021) (US$/Ton) Table 24. Hyperimmune Serum Manufacturers Manufacturing Base Distribution and Headquarters Table 25. Manufacturers Hyperimmune Serum Product Type Table 26. Date of International Manufacturers Enter into Hyperimmune Serum Market Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans Table 28. Global Hyperimmune Serum Sales by Type (2016-2021) (Kiloton) Table 29. Global Hyperimmune Serum Sales Share by Type (2016-2021) Table 30. Global Hyperimmune Serum Revenue by Type (2016-2021) (US$ Million) Table 31. Global Hyperimmune Serum Revenue Share by Type (2016-2021) Table 32. Hyperimmune Serum Average Selling Price (ASP) by Type (2016-2021) & (US$/Ton) Table 33. Global Hyperimmune Serum Sales Forecast by Type (2022-2027) & (Kiloton) Table 34. Global Hyperimmune Serum Sales Market Share Forecast by Type (2022-2027) Table 35. Global Hyperimmune Serum Revenue Forecast V (2022-2027) & (US$ Million) Table 36. Global Hyperimmune Serum Revenue Market Share Forecast by Type (2022-2027) Table 37. Global Hyperimmune Serum Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Ton) Table 38. Global Hyperimmune Serum Sales by Application (2016-2021) (Kiloton) Table 39. Global Hyperimmune Serum Sales Share by Application (2016-2021) Table 40. Global Hyperimmune Serum Revenue by Application (2016-2021) (US$ Million) Table 41. Global Hyperimmune Serum Revenue Share by Application (2016-2021) Table 42. Hyperimmune Serum Average Selling Price (ASP) by Application (2016-2021) & (US$/Ton) Table 43. Global Hyperimmune Serum Sales Forecast by Application (2022-2027) & (Kiloton) Table 44. Global Hyperimmune Serum Sales Market Share Forecast by Application (2022-2027) Table 45. Global Hyperimmune Serum Revenue Forecast by Application (2022-2027) & (US$ Million) Table 46. Global Hyperimmune Serum Revenue Market Share Forecast by Application (2022-2027) Table 47. Global Hyperimmune Serum Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Ton) Table 48. Japan Hyperimmune Serum Sales (Kiloton) of Key Companies (2016-2021) Table 49. Japan Hyperimmune Serum Sales Share by Company (2016-2021) Table 50. Japan Hyperimmune Serum Revenue (US$ Million) by Company (2016-2021) Table 51. Japan Hyperimmune Serum Revenue Share by Company (2016-2021) Table 52. Japan Hyperimmune Serum Sales (Kiloton) by Type (2016-2021) Table 53. Japan Hyperimmune Serum Sales Share by Type (2016-2021) Table 54. Japan Hyperimmune Serum Revenue (US$ Million) Market Share by Type (2016-2021) Table 55. Japan Hyperimmune Serum Price (US$/Ton) by Type (2016-2021) Table 56. Japan Hyperimmune Serum Sales (Kiloton) by Type (2022-2027) Table 57. Japan Hyperimmune Serum Sales Share by Type (2022-2027) Table 58. Japan Hyperimmune Serum Revenue (US$ Million) Market Share by Type (2022-2027) Table 59. Japan Hyperimmune Serum Revenue Share by Type (2022-2027) Table 60. Japan Hyperimmune Serum Price (US$/Ton) by Type (2022-2027) Table 61. Japan Hyperimmune Serum Sales (Kiloton) by Application (2016-2021) Table 62. Japan Hyperimmune Serum Sales Share by Application (2016-2021) Table 63. Japan Hyperimmune Serum Revenue (US$ Million) Market Share by Application (2016-2021) Table 64. Japan Hyperimmune Serum Price (US$/Ton) by Application (2016-2021) Table 65. Japan Hyperimmune Serum Sales (Kiloton) by Application (2022-2027) Table 66. Japan Hyperimmune Serum Sales Share by Application (2022-2027) Table 67. Japan Hyperimmune Serum Revenue (US$ Million) Market Share by Application (2022-2027) Table 68. Japan Hyperimmune Serum Revenue Share by Application (2022-2027) Table 69. Japan Hyperimmune Serum Price (US$/Ton) by Application (2022-2027) Table 70. North America Hyperimmune Serum Sales by Country (2016-2021) & (Kiloton) Table 71. North America Hyperimmune Serum Sales Market Share by Country (2016-2021) Table 72. North America Hyperimmune Serum Revenue by Country (2016-2021) & (US$ Million) Table 73. North America Hyperimmune Serum Revenue Market Share by Country (2016-2021) Table 74. Asia Pacific Hyperimmune Serum Sales by Region (2016-2021) & (Kiloton) Table 75. Asia Pacific Hyperimmune Serum Sales Market Share by Region (2016-2021) Table 76. Asia Pacific Hyperimmune Serum Revenue by Region (2016-2021) & (US$ Million) Table 77. Asia Pacific Hyperimmune Serum Revenue Market Share by Region (2016-2021) Table 78. Europe Hyperimmune Serum Sales by Country (2016-2021) & (Kiloton) Table 79. Europe Hyperimmune Serum Sales Market Share by Country (2016-2021) Table 80. Europe Hyperimmune Serum Revenue by Country (2016-2021) & (US$ Million) Table 81. Europe Hyperimmune Serum Revenue Market Share by Country (2016-2021) Table 82. Latin America Hyperimmune Serum Sales by Country (2016-2021) & (Kiloton) Table 83. Latin America Hyperimmune Serum Sales Market Share by Country (2016-2021) Table 84. Latin Americaa Hyperimmune Serum Revenue by Country (2016-2021) & (US$ Million) Table 85. Latin America Hyperimmune Serum Revenue Market Share by Country (2016-2021) Table 86. Middle East and Africa Hyperimmune Serum Sales by Country (2016-2021) & (Kiloton) Table 87. Middle East and Africa Hyperimmune Serum Sales Market Share by Country (2016-2021) Table 88. Middle East and Africa Hyperimmune Serum Revenue by Country (2016-2021) & (US$ Million) Table 89. Middle East and Africa Hyperimmune Serum Revenue Market Share by Country (2016-2021) Table 90. CSL Behring Corporation Information Table 91. CSL Behring Description and Business Overview Table 92. CSL Behring Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 93. CSL Behring Hyperimmune Serum Product Table 94. CSL Behring Recent Development Table 95. Grifols Corporation Information Table 96. Grifols Description and Business Overview Table 97. Grifols Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 98. Grifols Product Table 99. Grifols Recent Development Table 100. Biotest Corporation Information Table 101. Biotest Description and Business Overview Table 102. Biotest Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 103. Biotest Product Table 104. Biotest Recent Development Table 105. Kedrion Corporation Information Table 106. Kedrion Description and Business Overview Table 107. Kedrion Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 108. Kedrion Product Table 109. Kedrion Recent Development Table 110. CBPO Corporation Information Table 111. CBPO Description and Business Overview Table 112. CBPO Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 113. CBPO Product Table 114. CBPO Recent Development Table 115. Emergent (Cangene) Corporation Information Table 116. Emergent (Cangene) Description and Business Overview Table 117. Emergent (Cangene) Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 118. Emergent (Cangene) Product Table 119. Emergent (Cangene) Recent Development Table 120. Kamada Corporation Information Table 121. Kamada Description and Business Overview Table 122. Kamada Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 123. Kamada Product Table 124. Kamada Recent Development Table 125. CNBG Corporation Information Table 126. CNBG Description and Business Overview Table 127. CNBG Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 128. CNBG Product Table 129. CNBG Recent Development Table 130. Hualan Bio Corporation Information Table 131. Hualan Bio Description and Business Overview Table 132. Hualan Bio Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 133. Hualan Bio Product Table 134. Hualan Bio Recent Development Table 135. Shanghai RAAS Corporation Information Table 136. Shanghai RAAS Description and Business Overview Table 137. Shanghai RAAS Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 138. Shanghai RAAS Product Table 139. Shanghai RAAS Recent Development Table 140. Sichuan Yuanda Shuyang Corporation Information Table 141. Sichuan Yuanda Shuyang Description and Business Overview Table 142. Sichuan Yuanda Shuyang Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 143. Sichuan Yuanda Shuyang Product Table 144. Sichuan Yuanda Shuyang Recent Development Table 145. ADMA Biologics Corporation Information Table 146. ADMA Biologics Description and Business Overview Table 147. ADMA Biologics Hyperimmune Serum Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021) Table 148. ADMA Biologics Product Table 149. ADMA Biologics Recent Development Table 150. Hyperimmune Serum Market Trends Table 151. Hyperimmune Serum Market Drivers Table 152. Hyperimmune Serum Market Challenges Table 153. Hyperimmune Serum Market Restraints Table 154. Hyperimmune Serum Customers List Table 155. Hyperimmune Serum Distributors List Table 156. Research Programs/Design for This Report Table 157. Key Data Information from Secondary Sources Table 158. Key Data Information from Primary Sources List of Figures Figure 1. Hyperimmune Serum Product Picture Figure 2. Global Hyperimmune Serum Sales Market Share by Type in 2020 & 2027 Figure 3. Hepatitis B Immunoglobulins Product Picture Figure 4. Rabies Immunoglobulins Product Picture Figure 5. Tetanus Immunoglobulins Product Picture Figure 6. Rho(D) Immunoglobulins Product Picture Figure 7. Other Product Picture Figure 8. Global Hyperimmune Serum Sales Market Share by Application in 2020 & 2027 Figure 9. Government Institutions Figure 10. Private Sector Figure 11. Other Figure 12. Hyperimmune Serum Report Years Considered Figure 13. Global Hyperimmune Serum Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Hyperimmune Serum Market Size 2016-2027 (US$ Million) Figure 15. Global Hyperimmune Serum Sales 2016-2027 (Kiloton) Figure 16. Global Hyperimmune Serum Market Size Market Share by Region: 2021 Versus 2027 Figure 17. Global Hyperimmune Serum Sales Market Share by Region (2016-2021) Figure 18. Global Hyperimmune Serum Sales Market Share by Region in 2020 Figure 19. Global Hyperimmune Serum Revenue Market Share by Region (2016-2021) Figure 20. Global Hyperimmune Serum Revenue Market Share by Region in 2020 Figure 21. Global Hyperimmune Serum Sales Share by Manufacturer in 2020 Figure 22. The Top 10 and 5 Players Market Share by Hyperimmune Serum Revenue in 2020 Figure 23. Hyperimmune Serum Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 24. Global Hyperimmune Serum Sales Market Share by Type (2016-2021) Figure 25. Global Hyperimmune Serum Sales Market Share by Type in 2020 Figure 26. Global Hyperimmune Serum Revenue Market Share by Type (2016-2021) Figure 27. Global Hyperimmune Serum Revenue Market Share by Type in 2020 Figure 28. Global Hyperimmune Serum Sales Market Share by Application (2016-2021) Figure 29. Global Hyperimmune Serum Sales Market Share by Application in 2020 Figure 30. Global Hyperimmune Serum Revenue Market Share by Application (2016-2021) Figure 31. Global Hyperimmune Serum Revenue Market Share by Application in 2020 Figure 32. Japan Hyperimmune Serum Sales Growth Rate 2016-2027 (Kiloton) Figure 33. Japan Hyperimmune Serum Revenue Growth Rate 2016-2027 (US$ Million) Figure 34. Japan Hyperimmune Serum Market Share in Global Market 2016-2027 Figure 35. Japan 5 and 10 Largest Hyperimmune Serum Players Market Share by Revenue in Hyperimmune Serum in 2020 Figure 36. Japan Hyperimmune Serum Revenue Share by Type (2016-2021) Figure 37. Japan Hyperimmune Serum Revenue Growth Rate by Type in 2016 & 2020 Figure 38. Japan Hyperimmune Serum Revenue Share by Application (2016-2021) Figure 39. Japan Hyperimmune Serum Revenue Growth Rate by Application in 2016 & 2020 Figure 40. North America Hyperimmune Serum Sales Growth Rate 2016-2021 (Kiloton) Figure 41. North America Hyperimmune Serum Revenue Growth Rate 2016-2021 (US$ Million) Figure 42. North America Hyperimmune Serum Sales Market Share by Country in 2020 Figure 43. North America Hyperimmune Serum Revenue Market Share by Country in 2020 Figure 44. U.S. Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 45. U.S. Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Canada Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 47. Canada Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Europe Hyperimmune Serum Sales Growth Rate 2016-2021 (Kiloton) Figure 49. Europe Hyperimmune Serum Revenue Growth Rate 2016-2021 (US$ Million) Figure 50. Europe Hyperimmune Serum Sales Market Share by Country in 2020 Figure 51. Europe Hyperimmune Serum Revenue Market Share by Country in 2020 Figure 52. Germany Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 53. Germany Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. France Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 55. France Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. U.K. Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 57. U.K. Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Italy Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 59. Italy Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Russia Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 61. Russia Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 62. Asia Pacific Hyperimmune Serum Sales Growth Rate 2016-2021 (Kiloton) Figure 63. Asia Pacific Hyperimmune Serum Revenue Growth Rate 2016-2021 (US$ Million) Figure 64. Asia Pacific Hyperimmune Serum Sales Market Share by Region in 2020 Figure 65. Asia Pacific Hyperimmune Serum Revenue Market Share by Region in 2020 Figure 66. China Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 67. China Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. Japan Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 69. Japan Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. South Korea Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 71. South Korea Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. India Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 73. India Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Australia Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 75. Australia Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Taiwan Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 77. Taiwan Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Indonesia Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 79. Indonesia Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Thailand Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 81. Thailand Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Malaysia Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 83. Malaysia Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Philippines Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 85. Philippines Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Vietnam Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 87. Vietnam Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 88. Latin America Hyperimmune Serum Sales Growth Rate 2016-2021 (Kiloton) Figure 89. Latin America Hyperimmune Serum Revenue Growth Rate 2016-2021 (US$ Million) Figure 90. Latin America Hyperimmune Serum Sales Market Share by Country in 2020 Figure 91. Latin America Hyperimmune Serum Revenue Market Share by Country in 2020 Figure 92. Mexico Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 93. Mexico Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Brazil Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 95. Brazil Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Argentina Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 97. Argentina Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 98. Middle East and Africa Hyperimmune Serum Sales Growth Rate 2016-2021 (Kiloton) Figure 99. Middle East and Africa Hyperimmune Serum Revenue Growth Rate 2016-2021 (US$ Million) Figure 100. Middle East and Africa Hyperimmune Serum Sales Market Share by Country in 2020 Figure 101. Middle East and Africa Hyperimmune Serum Revenue Market Share by Country in 2020 Figure 102. Turkey Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 103. Turkey Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. Saudi Arabia Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 105. Saudi Arabia Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 106. UAE Hyperimmune Serum Sales Growth Rate (2016-2021) (Kiloton) Figure 107. UAE Hyperimmune Serum Revenue Growth Rate (2016-2021) (US$ Million) Figure 108. Hyperimmune Serum Value Chain Figure 109. Channels of Distribution Figure 110. Distributors Profiles Figure 111. Bottom-up and Top-down Approaches for This Report Figure 112. Data Triangulation Figure 113. Key Executives Interviewed

CSL Behring Grifols Biotest Kedrion CBPO Emergent (Cangene) Kamada CNBG Hualan Bio Shanghai RAAS Sichuan Yuanda Shuyang ADMA Biologics